Phenotypes associated with this allele
Allelic Composition |
Ercc6ltm1.2Ajlc/Ercc6l+
|
|
Genetic Background |
involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL/J |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc6ltm1.2Ajlc mutation
(0 available);
any
Ercc6l mutation
(6 available)
|
|
|
mortality/aging
|
• heterozygous females are obtained at sub-Mendelian ratios at 4 weeks of age, with ~20% dying either during the later stages of embryonic development or perinatally
• however, Mendelian ratios, embryo size and morphology are normal at E10.5, E11.5 and 12.5, and surviving females show normal appearance and body weight at ~1 year of age
|
reproductive system
|
• two of the heterozygous females studied did not produce any viable pups
|
|
• most heterozygous females exhibit reduced fertility
|
|
• heterozygous females mated with wild-type males produce fewer pups than wild-type females (4.6 +/- 2.3 versus 15.8 +/- 2.9) over a 14-week period
|
cellular
|
• MEFs obtained from E11.5 embryos show a mild but significant increase in the number of 53BP1 foci and micronuclei relative to wild-type MEFs
|
|
• MEFs are refractory to RASV12/E1A-induced transformation, giving rise to a smaller number of colonies than wild-type MEFs
|
|
• in culture, MEFs obtained from E11.5 embryos proliferate at a slightly lower rate than wild-type MEFs
|
|
• MEFs obtained from E11.5 embryos show a mild but significant increase in the number of 53BP1 foci and micronuclei relative to wild-type MEFs
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc6ltm1.2Ajlc mutation
(0 available);
any
Ercc6l mutation
(6 available)
Trp53tm1Tyj mutation
(12 available);
any
Trp53 mutation
(232 available)
|
|
|
mortality/aging
|
• no viable mice are born
|
embryo
|
• at E10.5, embryos show a significant increase in the number of apoptotic cells, as determined by IHC staining for cleaved caspase-3
|
cellular
|
• at E10.5, embryos show a significant increase in the number of apoptotic cells, as determined by IHC staining for cleaved caspase-3
|
|
• at E10.5, embryos exhibit an increase in the proportion of gamma-H2AX-positive cells relative to wild-type embryos
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc6ltm1.2Ajlc mutation
(0 available);
any
Ercc6l mutation
(6 available)
Trp53tm1Tyj mutation
(12 available);
any
Trp53 mutation
(232 available)
|
|
|
mortality/aging
|
• no viable mice are born, suggesting that p53-dependent apoptosis and senescence are unlikely to be the only drivers of embryonic lethality
|
embryo
|
• at E10.5, embryos show a significant increase in the number of apoptotic cells, as determined by IHC staining for cleaved caspase-3
|
|
• embryos are smaller at E10.5
|
growth/size/body
|
• embryos are smaller at E10.5
|
cellular
|
• at E10.5, embryos show a significant increase in the number of apoptotic cells, as determined by IHC staining for cleaved caspase-3
|
|
• at E10.5, embryos exhibit an increase in the proportion of gamma-H2AX-positive cells relative to wild-type embryos
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc6ltm1.2Ajlc mutation
(0 available);
any
Ercc6l mutation
(6 available)
Trp53tm1Tyj mutation
(12 available);
any
Trp53 mutation
(232 available)
|
|
|
mortality/aging
|
• only one female is born out of 7 expected, indicating that the proportion of viable births is further reduced in a Trp53 null background
|
Allelic Composition |
Ercc6ltm1.2Ajlc/Y
|
|
Genetic Background |
involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL/J |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ercc6ltm1.2Ajlc mutation
(0 available);
any
Ercc6l mutation
(6 available)
|
|
|
mortality/aging
|
• male embryos are obtained at a lower than expected frequency at E10.5, E11.5, E12.5, and E13.5
• most embryos lose viability at or before E13.5 and no males are born
|
embryo
|
• at E10.5, embryos show a significant increase in the number of apoptotic cells, as determined by IHC staining for cleaved caspase-3
|
|
• male embryos show a general developmental arrest at E12.5 and E13.5
|
|
• male embryos are grossly normal but smaller at E10.5; embryo length reduction becomes more evident after E11.5
|
growth/size/body
|
• male embryos are grossly normal but smaller at E10.5; embryo length reduction becomes more evident after E11.5
|
nervous system
|
• at E10.5, embryos show a significant increase in the number of cleaved caspase-3-positive cells in the brain
|
cellular
|
• mouse embryonic fibroblasts (MEFs) obtained from E11.5 and E12.5 embryos exhibit increased levels of 53BP1 nuclear foci and micronucleus formation
|
|
• MEFs obtained from E11.5 and E12.5 embryos exhibit polyploidy
|
|
• MEFs are resistant to RASV12/E1A-induced transformation, as indicated by their inability to form colony colonies
|
|
• MEFs obtained from E11.5 and E12.5 embryos show a greater tendency to accumulate in the G2 cell-cycle phase relative to wild-type MEFs
|
|
• at E10.5, embryos show a significant increase in the number of apoptotic cells, as determined by IHC staining for cleaved caspase-3
|
|
• at E10.5, embryos show a significant increase in the number of cleaved caspase-3-positive cells in the brain
|
|
• in culture, MEFs obtained from E11.5 and E12.5 embryos proliferate at a lower rate than wild-type MEFs from passage one and stop proliferating after 4 passages
|
|
• MEFs obtained from E11.5 and E12.5 embryos enter into a senescent state after only 3-4 passages in culture, as determined by senescence-associated beta-galactosidase staining
|
|
• at early passages, MEFs obtained from E11.5 and E12.5 embryos exhibit poor EdU incorporation, indicating a very limited replicative capacity
|
|
• at E10.5, embryos exhibit an increase in the proportion of gamma-H2AX-positive cells; DNA damage is detected in all embryonic tissues but is particularly evident in embryonic brain
• a high number of p53 positive cells is observed throughout the embryo at E10.5 and onward, indicating extensive p53 activation
• MEFs obtained from E11.5 and E12.5 embryos show phenotypes associated with genome instability, including increased levels of 53BP1 nuclear foci, micronucleus formation and polyploidy
|
homeostasis/metabolism